MasterPharm Recalls Testosterone/Anastrozole Pellets Due to Processing Control Deficiencies
MasterPharm LLC is recalling Testosterone/Anastrozole Pellets 100/6 mg due to a lack of processing controls that ensures conformity to specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or hospitalizations. The hazard is a theoretical risk related to processing controls rather than a confirmed high-risk pathogen or structural defect, fitting the criteria for a moderate severity score.
Plain-English summary
MasterPharm LLC is recalling Testosterone/Anastrozole Pellets 100/6 mg, 100 pellets per bottle. The recall was initiated because of a lack of processing controls, which means there is a lack of assurance that the product conforms to its specifications.
The affected product is distributed nationwide in the U.S. The specific code information for the recalled items is 02-10-2020:06@32, with a best use date of 8/2/2020. The total quantity involved in this recall is 339 pellets.
Consumers who have this product should stop using it and contact MasterPharm LLC at (866) 630-5600 for further instructions on how to return or dispose of the medication.
The recalled product
- Product
- Testosterone/Anastrozole Pellet 100/6 mg, 100 pellets per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419 (866) 630-5600
- Manufacturer
- MasterPharm LLC
- Category
- Drug — Compounded Medication
- Affected units
- 339
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 02-10-2020:06@32
- BUD 8/2/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 26 recalled by MasterPharm LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 26 products in this recall →Related recalls
Same manufacturer · MasterPharm LLC
See all →- ModerateMasterPharm Recalls Tadalafil 12 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Formula 82M Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
Same hazard · processing control deficiency
See all →- ModerateDoxycycline oral suspension recalled for insanitary manufacturing conditions
FDA (Drugs) · 2022-07-13
- SevereRedline Pharmacy Recalls Morphine Sulfate Due to Processing Control Deficiencies
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Vancomycin Injectable Due to Processing Control Deficiencies
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Ertapenem Injectable Due to Processing Control Issues
FDA (Drugs) · 2020-03-18
- ModerateConversio Health Recalls Albuterol and Ipratropium Inhalation Vials
FDA (Drugs) · 2019-11-27